Saudi Arabia Forms Pharmaceutical Firm to Boost Sector's Growth

With the purpose of supporting Saudi Arabia's position as a global pharmaceutical manufacturing destination, Lifera intends to manufacture life-saving and essential pharmaceutical products, including insulin, vaccines, plasma therapeutics, monoclonal antibodies, cell and gene therapies, and innovative small molecules, according to a PIF statement.

The new company will also create partnerships with leading local and international companies and attract targeted investments to drive domestic manufacturing capacity.

Since 2017, the PIF has established 79 companies across its 13 strategic sectors.

4155/v